secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bionano Genomics, Inc. (BNGO)
CIK:        0001411690
Form:       8-K
Filed at:   2024-04-05T23:59:59+00:00
Accession:  0001140361-24-018181
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bionano Genomics raises $10M via registered direct offering of common stock and warrants at $1.145/share
--------------------------------------------------------------------------------

- Issues 8.73M shares (or equivalents) and warrants to purchase 8.73M shares at $1.02; exercise price $1.02, 5-year term.
- Gross proceeds ~$10M; net proceeds for working capital, R&D, debt repayment, and capex.
- Expected closing on April 8, 2024; H.C. Wainwright acts as sole placement agent with 6% cash fee.
- Offered under effective shelf registration statement (File No. 333-270459); warrants include beneficial ownership limitations of 4.99%/9.99%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1411690/000114036124018181/0001140361-24-018181-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1411690/000114036124018181/ef20026117_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-018181

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer